Colon Cancer Treatment

Comprehensive colorectal cancer care including adjuvant therapy, metastatic disease management, and personalized treatment approaches for optimal outcomes.

7+
Years Experience
700+
Colon Cancer Patients
94%
5-Year Survival Rate

Advanced Colon Cancer Treatment

Expert management of colorectal cancer from early-stage adjuvant therapy to advanced metastatic disease. We specialize in FOLFOX, FOLFIRI regimens, targeted therapies, and comprehensive multidisciplinary care.

Diagnosis & Staging

Colonoscopy & Imaging

Complete colonoscopy with biopsy, CT colonography, and staging imaging for accurate diagnosis.

Molecular Testing

KRAS, NRAS, BRAF, MSI testing, and comprehensive genomic profiling for treatment selection.

Pathological Staging

TNM staging, tumor grade, lymphovascular invasion, and margin assessment for prognosis.

Treatment Options

Adjuvant Chemotherapy

Post-surgical chemotherapy for stage II-III colon cancer to reduce recurrence risk.

  • FOLFOX (5-FU + Oxaliplatin)
  • CAPOX (Capecitabine + Oxaliplatin)
  • 5-FU/LV regimens
  • Duration optimization

Targeted Therapy

Precision medicine for metastatic colorectal cancer with monoclonal antibodies and TKIs.

  • Bevacizumab (Avastin)
  • Cetuximab (Erbitux)
  • Panitumumab (Vectibix)
  • Regorafenib (Stivarga)

Immunotherapy

Advanced immunotherapy for MSI-high colorectal cancer and clinical trials.

  • Pembrolizumab (Keytruda)
  • Nivolumab (Opdivo)
  • Nivolumab + Ipilimumab
  • Clinical trial combinations

Common Symptoms

Change in Bowel Habits

Diarrhea/constipation, narrower stools, feeling of incomplete evacuation, urgency.

Blood in Stool

Rectal bleeding or dark stools; iron-deficiency anemia causing fatigue and pallor.

Abdominal Symptoms

Cramping, pain, bloating, unexplained weight loss and appetite loss.

Risk Factors

Hereditary Syndromes

Lynch syndrome, FAP, strong family history, personal history of polyps/IBD.

Diet & Lifestyle

High red/processed meat intake, obesity, smoking, alcohol, inactivity.

Age & Metabolic

Age over 50, type 2 diabetes, metabolic syndrome increase risk.

Follow-up Care